股本结构
单位：万股
| 公告日期 | 2026-03-30 | 2026-03-30 | 2025-08-13 | 2025-07-31 | 2025-06-26 | 2025-05-27 |
|---|---|---|---|---|---|---|
| 证券总股本 | 622.33 | 589.48 | 524.68 | 609.48 | 404.48 | 336.70 |
| 普通股本 | 622.33 | 589.48 | 524.68 | 609.48 | 404.48 | 336.70 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2026-03-30 | 2025-12-31 | 2025-08-13 | 2025-07-30 | 2025-06-26 | 2025-05-27 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2026-03-30 | 622.33 | 未披露 | 定期报告 | 2026-03-30 |
| 2026-03-30 | 589.48 | 未披露 |
更多>>
From January 1, 2025 to December 31, 2025
Common shares issued through private placements offerings
Common shares issued as debts settlement
Common shares issued upon pre-funded warrants exercised
Common shares issued upon debentures converted
Common shares issued as consideration upon acquisition of non-controlling interest
|
2025-12-31 |
| 2025-08-13 | 524.68 | 未披露 | 定期报告 | 2025-08-13 |
| 2025-07-31 | 609.48 | 未披露 |
更多>>
Ordinary shares offered 2,050,000 shares by the company.
|
2025-07-30 |
| 2025-06-26 | 404.48 | 未披露 | 定期报告 | 2025-06-26 |
| 2025-05-27 | 336.70 | 未披露 | 定期报告 | 2025-05-27 |
| 2024-12-04 | 308.55 | 未披露 | 定期报告 | 2024-11-30 |
| 2024-09-09 | 223.24 | 未披露 | 定期报告 | 2024-08-31 |
| 2024-07-05 | 223.24 | 未披露 |
更多>>
IM Cannabis Corp. a leading medical cannabis company with operations in Israel and Germany, announces that the board of directors of the Company has approved a consolidation of its issued and outstanding common shares on the basis of one post-consolidated Common Share for every six pre-consolidated Common Shares.
|
2024-07-12 |
| 2023-08-02 | 1339.41 | 未披露 | 定期报告 | 2023-07-31 |
| 2023-05-15 | 1338.96 | 未披露 | 定期报告 | 2023-05-15 |
| 2023-03-07 | 1284.66 | 未披露 | 定期报告 | 2023-02-28 |
| 2023-02-07 | 1115.08 | 未披露 | 定期报告 | 2023-01-31 |
| 2022-11-15 | 756.95 | 未披露 |
更多>>
IM Cannabis Corp. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated common share for every ten (10) pre-consolidated common shares.
|
2022-11-17 |
| 2022-10-11 | 7569.53 | 未披露 | 定期报告 | 2022-10-07 |
| 2022-08-25 | 7458.28 | 未披露 | 定期报告 | 2022-08-24 |
| 2022-04-11 | 6969.53 | 未披露 | 定期报告 | 2022-04-11 |
| 2022-03-30 | 6969.02 | 未披露 | 定期报告 | 2022-03-30 |
| 2022-03-15 | 6943.92 | 未披露 | 定期报告 | 2022-03-15 |
| 2022-03-07 | 6843.01 | 未披露 | 定期报告 | 2022-02-28 |
| 2022-02-07 | 6822.18 | 未披露 | 定期报告 | 2022-01-31 |
| 2022-04-04 | 6821.79 | 未披露 |
更多>>
From December 31, 2020 to December 31, 2021
Issuance of common shares, net of issuance costs of $3,800
Exercise of warrants and compensation options
Exercise of options
Forfeited options
|
2021-12-31 |
| 2021-12-07 | 6818.42 | 未披露 | 定期报告 | 2021-11-30 |
| 2021-11-05 | 6783.80 | 未披露 | 定期报告 | 2021-10-31 |
| 2021-11-24 | 6758.20 | 未披露 | 定期报告 | 2021-09-30 |
| 2021-09-09 | 6729.84 | 未披露 | 定期报告 | 2021-08-31 |
| 2021-08-10 | 6729.85 | 未披露 | 定期报告 | 2021-07-31 |
| 2021-08-17 | 5708.30 | 未披露 |
更多>>
From January 1, 2021 to June 30, 2021
Common Shares issued as a result of Warrants and Compensation options exercised
Common Shares issued as a result of options exercised
Common Shares issued as a result of finance equity round
|
2021-06-30 |
| 2021-06-08 | 5706.77 | 未披露 | 定期报告 | 2021-05-31 |
| 2021-05-06 | 5097.54 | 未披露 | 定期报告 | 2021-05-04 |
| 2021-05-05 | 5050.10 | 未披露 | 定期报告 | 2021-05-03 |
| 2021-05-18 | 5049.80 | 未披露 |
更多>>
From January 1, 2021 to March 30, 2021
Common Shares issued as a result of Warrants and Compensation options exercised
Common Shares issued as a result of options exercised
Common Shares issued in consideration of a business combination
|
2021-03-30 |
| 2021-03-15 | 4025.88 | 未披露 | 定期报告 | 2021-03-11 |
| 2021-02-12 | 14574.33 | 未披露 | 定期报告 | 2021-03-01 |
From January 1, 2025 to December 31, 2025
Common shares issued through private placements offerings
Common shares issued as debts settlement
Common shares issued upon pre-funded warrants exercised
Common shares issued upon debentures converted
Common shares issued as consideration upon acquisition of non-controlling interest
Ordinary shares offered 2,050,000 shares by the company.
IM Cannabis Corp. a leading medical cannabis company with operations in Israel and Germany, announces that the board of directors of the Company has approved a consolidation of its issued and outstanding common shares on the basis of one post-consolidated Common Share for every six pre-consolidated Common Shares.
IM Cannabis Corp. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated common share for every ten (10) pre-consolidated common shares.
From December 31, 2020 to December 31, 2021
Issuance of common shares, net of issuance costs of $3,800
Exercise of warrants and compensation options
Exercise of options
Forfeited options
From January 1, 2021 to June 30, 2021
Common Shares issued as a result of Warrants and Compensation options exercised
Common Shares issued as a result of options exercised
Common Shares issued as a result of finance equity round
From January 1, 2021 to March 30, 2021
Common Shares issued as a result of Warrants and Compensation options exercised
Common Shares issued as a result of options exercised
Common Shares issued in consideration of a business combination